BioNTech SE (BNTX) Current Taxes (2018 - 2025)
BioNTech SE (BNTX) reported Current Taxes of $76.4 million for Q4 2025, up 1487.99% on a YoY basis from $4.8 million in Q4 2024, and up 936.81% sequentially from $7.4 million in Q3 2025.
BioNTech SE (BNTX) Current Taxes (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 7 years of Current Taxes data on file, last reported at $76.4 million in Q4 2025.
- For the quarter ending Q4 2025, Current Taxes rose 1487.99% year-over-year to $76.4 million; the trailing twelve-month figure through Dec 2025 stood at $76.4 million (up 1487.99% YoY), and the FY2025 full-year result was $74.1 million, up 1441.29% from the prior year.
- Current Taxes rose to $76.4 million in Q4 2025, from $7.4 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $1.8 billion in Q1 2022 to a low of $4.2 million in Q2 2025.
- A 5-year average of $629.2 million and a median of $565.2 million in 2023 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes plunged 99.15% in 2024 and jumped 1487.99% in 2025, its largest moves.
- Tracing BNTX's Current Taxes over 5 years: stood at $1.8 billion in 2021, then tumbled by 66.13% to $608.0 million in 2022, then declined by 7.0% to $565.4 million in 2023, then plunged by 99.15% to $4.8 million in 2024, then surged by 1487.99% to $76.4 million in 2025.
- Business Quant data shows BNTX's Current Taxes at $76.4 million in Q4 2025, $7.4 million in Q3 2025, and $4.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | 76.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.36 Mn |
| Sep 30, 2025 | 7.37 Mn |
| Jun 30, 2025 | 4.19 Mn |
| Mar 31, 2025 | 5.68 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | 399.31 Mn |
| Jun 30, 2024 | 393.28 Mn |
| Mar 31, 2024 | 383.70 Mn |
| Dec 31, 2023 | 565.41 Mn |
| Sep 30, 2023 | 593.50 Mn |
| Jun 30, 2023 | 604.24 Mn |
| Mar 31, 2023 | 564.90 Mn |
| Dec 31, 2022 | 607.97 Mn |
| Sep 30, 2022 | 1.40 Bn |
| Jun 30, 2022 | 1.51 Bn |
| Mar 31, 2022 | 1.81 Bn |
| Dec 31, 2021 | 1.79 Bn |
| Mar 31, 2021 | 596.97 Mn |
| Dec 31, 2019 | 166,033.15 |
| Sep 30, 2019 | 330,480.82 |